These results illustrate that c-myc overexpression can reverse the effect of PTTG silence on aerobic glycolysis and mitochondrial metabolism, further demonstrating that the effect of PTTG on the metabolic reprogramming of ovarian cancer cells is mediated by the c-myc pathway. The gene discussed is PTTG1; the disease is ovarian carcinoma.